Moneycontrol PRO
Upcoming Webinar:Join us for Sustainability 100+ Dialogues 2021-Maharashtra Roundtable& know how the state is progressing on climate action
you are here: HomeNewsIndia

COVID-19 Vaccines | Anxiety responsible for more than 50% of adverse reactions: Report

Among other reasons, 18 were vaccine product-related, one was classified as both anxiety and vaccine related, while 5 were casual association or ‘coincidental cases’

July 22, 2021 / 10:25 AM IST
Fear of needles and vaccine hesitancy were the top causes of anxiety. (Representative image)

Fear of needles and vaccine hesitancy were the top causes of anxiety. (Representative image)

A study of 60 serious adverse effects cases after COVID-19 jabs, conducted by the National Adverse Events Following Immunisation Committee (National AEFI Committee), found that 36 of them – over 50 percent, were related to anxiety.

As per the casualty assessment report of the study, “36 of the 60 cases were related to anxiety, 18 were vaccine product-related, one was classified as both anxiety and vaccine-related, while 5 were casual association or ‘coincidental cases’ and not linked to vaccination”, The Economic Times reported.

Among the 5 coincidental cases, one person died, it noted. “Coincidental event” denotes that while the death occurred after vaccination, there could have been other causes.

Follow our LIVE blog on the COVID-19 pandemic here

Demographics-wise, most of the anxiety-related cases were women, with fear of needles and vaccine hesitancy being the biggest causes, a senior official told the paper. Adding: “We have to see how to overcome needle phobia. This has been reported more in women.”


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

In terms of vaccines, 57 cases studied were administered Covishield, while 3 received Covaxin.

Overall the small study found that the benefits of vaccination outweigh the risk of harm, but the report noted that “all emerging signals of harm are being constantly tracked and reviewed periodically as a measure of utmost precaution”.

The report was completed on May 27, after “thorough approval, deliberation and review” by the National AEFI Committee. It was submitted to the Health Ministry on July 8.

The special committee was constituted by the ministry to conduct causality assessment post-COVID-19 vaccination and consists of cardiologists, neurologists, medical specialists, obstetrician-gynaecologist and pulmonary medicine specialists.

For full coverage on the coronavirus pandemic click here
Moneycontrol News
first published: Jul 22, 2021 10:25 am

stay updated

Get Daily News on your Browser
ISO 27001 - BSI Assurance Mark